Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M103Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-9.8
Enterprise Value $M84.1EPS (TTM) $-1.1Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)--Higher ROA y-yN
Price/Book87.810-y EBITDA Growth Rate %-6.5Quick Ratio11.4Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-16.7Current Ratio11.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-122.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-195.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M25.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RNN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RNN is held by these investors:



RNN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ahn Chang HoDirector 2017-04-10Sell25,000$7-42.29view
Jeong Tae HeumCFO 2015-01-12Sell31,727$9.1-55.6view
Ahn Chang HoDirector 2015-01-12Sell31,466$9.1-55.6view
Ahn Chang HoDirector 2014-06-12Sell13,619$9.9-59.19view
Jeong Tae HeumCFO 2013-09-09Sell7,114$4.6-12.17view
Kivel RichardDirector 2011-10-03Buy250$10.4-61.15view
Brandt Peter C.Director 2011-09-09Buy12,500$11.7-65.47view
Brandt Peter C.Director 2011-09-07Buy2,500$9.6-57.92view
Ahn Chang HoChairman & CEO, 10% Owner 2011-05-18Buy100,808$13.1-69.16view
Ahn Chang HoChairman & CEO, 10% Owner 2011-04-01Buy32,085$12.2-66.89view

Quarterly/Annual Reports about RNN:

News about RNN:

Articles On GuruFocus.com
Rexahn Pharmaceuticals to Present RX-3117 Clinical Data at the American Society of Clinical Oncology May 08 2017 
Rexahn Effects 1-for-10 Reverse Stock Split May 05 2017 
Rexahn Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update May 04 2017 
Rexahn Announces 1-for-10 Reverse Stock Split Apr 13 2017 
Weekly CEO Buys Highlight: RNN, IIG, FSC, GEO, DAN May 21 2011 
Weekly CEO Buys Highlight: GBDC, EXL, RNN, KYN, CMTL Apr 09 2011 

More From Other Websites
Today's Research Reports on Stocks to Watch: Rexahn Pharmaceuticals and Depomed May 12 2017
Rexahn Pharmaceuticals to Present RX-3117 Clinical Data at the American Society of Clinical Oncology... May 08 2017
Rexahn Effects 1-for-10 Reverse Stock Split May 05 2017
Rexahn reports 1Q loss May 04 2017
Rexahn Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update May 04 2017
Rexahn Announces 1-for-10 Reverse Stock Split Apr 13 2017
Penny Stocks to Watch for April 2017 (ATRS, WRN) Mar 31 2017
BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values Rise Slightly Mar 28 2017
Trade Volume Can Speak a Lot About Momentum of a Stock Mar 16 2017
Rexahn Pharmaceuticals (RNN) Jumps: Stock Moves Up 5.4% Mar 16 2017
Rexahn Pharmaceuticals to Present at the 2nd Annual Disruptive Growth & Healthcare Conference Feb 06 2017
Rexahn Pharmaceuticals Nears 52-Week Low (RNN) Oct 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)